Last reviewed · How we verify

NCT04497623: SabanaHerons

Clinical Evaluation of Ventilador Innovation Product in Colombia in the SARS COVID 19 Pandemic, Unisabana Herons.

Completed NA Last updated 24 September 2020
What this trial tests

NA trial testing Invasive mechanical ventilation using the Unisabana-Herons Ventilator during 24 hours in Covid19 in 5 participants. Completed in 20 September 2020.

Timeline
28 July 2020
Primary endpoint
13 August 2020
20 September 2020

Quick facts

Lead sponsorFundación Neumologica Colombiana
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposedevice feasibility
Enrollment5
Start date28 July 2020
Primary completion13 August 2020
Estimated completion20 September 2020
Sites3 locations across Colombia

Drugs / interventions tested

Conditions studied

Sponsor

Fundación Neumologica Colombiana

Who can join

Adults 18 to 70, any sex, with Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to evaluate the efficacy and safety of the Unisabana-Herons invasive mechanical ventilator designed to provide the basic ventilatory support necessary to preserve the life of patients with respiratory failure and indication of mechanical ventilation, especially for those who suffer from acute respiratory distress syndrome (ARDS) when conventional commercial invasive ventilators are not available in the context of the health emergency due to the COVID-19 epidemic. The Unisabana-Herons ventilator allows to precisely configure the respiratory rate, tidal volume (or inspired air volume), inspiratory time, the inspiration: expiration ratio, the positive pressure at the end of expiration (PEEP), the inspired fraction of oxygen and inspiratory air flow, parameters that allow managing the respiratory failure associated with COVID-19. The ventilator also monitors peak inspiratory pressures (PIP), mean, PEEP, plateau, and graphs in real time the pressure-time, volume-time, flow-time curves, which allows detecting when one of these is at levels dangerous to induce ventilator trauma (barotrauma and volutrauma) and thus ensure effective and safe ventilation, so as to avoid ventilator-induced lung injury.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The development and implementation of a low-cost mechanical ventilator in a low-middle-income country during the COVID-19 pandemic: The Unisabana-HERONS.
    Giraldo-Cadavid LF, Echeverry J, Varón-Vega F, Bastidas A, et al · · 2024 · cited 1× · PMID 38756610 · DOI 10.1016/j.heliyon.2024.e30671

Verify or expand the search:

Other recruiting trials for Covid19

Currently open trials in the same condition.

Other Fundación Neumologica Colombiana trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04497623.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing